mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.1 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.1 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.12 |
0.2 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |